Evidence map›Paper›PMID 35594028›Full record

ArticleJournal of applied clinical medical physics2022

Sigmoid model analysis of breast dynamic contrast-enhanced MRI: Distinguishing between benign and malignant breast masses and breast cancer subtype prediction.

Norikazu Koori, Tosiaki Miyati, Naoki Ohno, Hiroko Kawashima, Hiroko Nishikawa

Open access · goldAbstract read
In one paragraph

Article in Journal of applied clinical medical physics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Norikazu KooriDepartment of Radiology, Komaki City Hospital, Komaki, Aichi, Japan.ORCID https://orcid.org/0000-0003-1086-3945
Tosiaki MiyatiDivision of Health Sciences, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Ishikawa, Japan.ORCID https://orcid.org/0000-0001-6120-2990
Naoki OhnoDivision of Health Sciences, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Ishikawa, Japan.ORCID https://orcid.org/0000-0002-7720-8040
Hiroko KawashimaDivision of Health Sciences, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Ishikawa, Japan.
Hiroko NishikawaDepartment of Radiology, Komaki City Hospital, Komaki, Aichi, Japan.
Kanazawa University · JPKomaki City Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is performed to distinguish between benign and malignant lesions by evaluating the changes in signal intensity of the acquired image (kinetic curve). This study aimed to verify whether the existing breast DCE-MRI analyzed by the sigmoid model can accurately distinguish between benign and invasive ductal carcinoma (IDC) and predict the subtype. A total of 154 patients who underwent breast MRI for detailed breast mass examinations were included in this study (38 with benign masses and 116 with IDC. The sigmoid model involved the acquisition of images at seven timepoints in 1-min intervals to determine the change in signal intensity before and after contrast injection. From this curve, the magnitude of the increase in signal intensity in the early phase, the time to reach the maximum increase, and the slopes in the early and late phases were calculated. The Mann-Whitney U-test was used for the statistical analysis. The IDC group exhibited a significantly larger and faster signal increase in the early phase and a significantly smaller rate of increase in the late phase than the benign group (P < 0.001). The luminal A-like group demonstrated a significantly longer time to reach the maximum signal increase rate than other IDC subtypes (P < 0.05). The sigmoid model analysis of breast DCE-MRI can distinguish between benign lesions and IDC and may also help in predicting luminal A-like breast cancer.

Indexed as

Breast NeoplasmsBreastContrast MediaDiagnosis, DifferentialFemaleHumansMagnetic Resonance ImagingRetrospective StudiesContrast Mediabreast dynamic contrast-enhanced MRIDCE-MRIinvasive ductal carcinomasigmoid model

Identifiers

PMID35594028
PMCPMC9195041
OpenAlexW4281250963

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.